Surmodics | SRDX - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Align Technology USD 1.92B 46.45M 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Artivion USD 101.56M 15.72M 2025-12
Baxter International USD 2.97B 805M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
EDAP TMS EUR 31.4M 2.71M 2025-09
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Haemonetics USD 539.87M 8.45M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
J&J USD 54.13B 3.26B 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Mesa Laboratories USD 54.4M 6.1M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Option Care Health USD 829.35M 5.44M 2025-12
Stryker USD 7.79B 380M 2025-12
Surmodics USD 19.44M 1.1M 2025-06
Trinity Biotech USD 34.49M 2.97M 2025-09